explore -WSS

explore

author：fashion 2025-09-28 00:51:38 - browse：15

After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： UnitedHealth financials solid despite Change Healthcare cyberattack

WSS

FTC falls short on scrutinizing hospital mergers, study says

Cholera vaccine supply gets boost as demand surges globally

FTC falls short on scrutinizing hospital mergers, study says

Popular nasal decongestant doesn't actually relieve congestion

Exact Sciences stock tumbles despite strong cancer detection sales

After traumatic brain injury, life support decisions can use more time

hotspot

explore

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Popular nasal decongestant doesn't actually relieve congestion

Malaria cases in Florida and Texas: Here’s what you need to know

Food makers tried to stack nutrition panel with preferred experts

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Exact Sciences stock tumbles despite strong cancer detection sales

United colonoscopy coverage change 'may cost lives,' doctors say

Close Medicare's dangerous gaps in addiction treatment coverage

The cancer drug shortage isn’t new — and neither are the solutions

After traumatic brain injury, life support decisions can use more time

Wikipedia

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Private equity could exacerbate cardiology's overuse problem, experts fear

Hospitals consider fixing cancer drug shortages on their own

IRA could hurt research into orphan drugs for rare diseases

Regeneron agrees to White House price limits on anti

FTC falls short on scrutinizing hospital mergers, study says

focus

focus

focus

knowledge